2SH-16961-36850
2 vaccinations
3 coded responses
10 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-02-15
Registered in v-safe
-
2021-02-15
Dose 2 — Moderna
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: No appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-19
- 2021-02-20
-
2021-03-08
Survey response — day 21, dose 2MedDRA: Throat irritation, Upper-airway cough syndrome — Feeling: GoodFree text: Post nasal drip, irritated throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-05-17
-
2021-08-16
Survey response — 6 months, dose 2MedDRA: Biochemical pregnancy, Nasopharyngitis, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: 2 chemical pregnancies Long lasting cold · Healthcare visit (other): Appointment scheduled but not yet completedMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-16
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-15 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-16 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): No appetite
Release 5 — day 21, dose 2
Symptoms: Post nasal drip, irritated throat
Release 9 — 6 months, dose 2
Symptoms: 2 chemical pregnancies Long lasting cold
Healthcare visit (other): Appointment scheduled but not yet completed
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Biochemical pregnancy | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release